Nina Paleologos to Chemoradiotherapy, Adjuvant
This is a "connection" page, showing publications Nina Paleologos has written about Chemoradiotherapy, Adjuvant.
Connection Strength
0.032
-
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study. Neuro Oncol. 2015 Jun; 17(6):854-61.
Score: 0.032